• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
In Regard to Joseph et al. (2023) (https://doi.org/10.1007/s12070-023-04416-7).关于约瑟夫等人（2023年）（https://doi.org/10.1007/s12070-023-04416-7）。
Indian J Otolaryngol Head Neck Surg. 2024 Aug;76(4):3735-3736. doi: 10.1007/s12070-024-04580-4. Epub 2024 Mar 11.
2
Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis.老年新诊断胶质母细胞瘤的治疗：一项网状Meta分析
Cochrane Database Syst Rev. 2020 Mar 23;3(3):CD013261. doi: 10.1002/14651858.CD013261.pub2.
3
Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.治疗口腔和口咽癌的干预措施：化疗。
Cochrane Database Syst Rev. 2021 Dec 20;12(12):CD006386. doi: 10.1002/14651858.CD006386.pub4.
4
The Changing Therapeutic Role of Chemo-radiotherapy for Loco-regionally Advanced Nasopharyngeal Carcinoma from Two/Three-Dimensional Radiotherapy to Intensity-Modulated Radiotherapy: A Network Meta-Analysis.从二维/三维放疗到调强放疗：局部晚期鼻咽癌化放疗治疗作用的变化：一项网状荟萃分析。
Theranostics. 2017 Oct 17;7(19):4825-4835. doi: 10.7150/thno.21815. eCollection 2017.
5
Surgery for limited-stage small-cell lung cancer.局限期小细胞肺癌的手术治疗
Cochrane Database Syst Rev. 2017 Apr 21;4(4):CD011917. doi: 10.1002/14651858.CD011917.pub2.
6
Chemotherapy, radiotherapy and combined modality for Hodgkin's disease, with emphasis on second cancer risk.霍奇金淋巴瘤的化疗、放疗及综合治疗模式，重点关注二次癌症风险。
Cochrane Database Syst Rev. 2005 Oct 19;2005(4):CD003187. doi: 10.1002/14651858.CD003187.pub2.
7
Interventions for the treatment of oral and oropharyngeal cancers: targeted therapy and immunotherapy.口腔和口咽癌的治疗干预措施：靶向治疗和免疫治疗。
Cochrane Database Syst Rev. 2015 Dec 1;2015(12):CD010341. doi: 10.1002/14651858.CD010341.pub2.
8
Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.未治疗的霍奇金淋巴瘤患者化疗和放疗在第二原发性恶性肿瘤、总生存期和无进展生存期方面的优化：个体参与者数据分析
Cochrane Database Syst Rev. 2017 Sep 13;9(9):CD008814. doi: 10.1002/14651858.CD008814.pub2.
9
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
10
Interventions for the treatment of oral cavity and oropharyngeal cancers: surgical treatment.口腔和口咽癌的治疗干预措施：手术治疗。
Cochrane Database Syst Rev. 2023 Aug 31;8(8):CD006205. doi: 10.1002/14651858.CD006205.pub5.

本文引用的文献

1
Outcome of Adjuvant Radiotherapy and Adjuvant Chemoradiation for Oral Cancers with Close Margins of Resection.口腔癌手术切缘接近时辅助放疗及辅助放化疗的疗效
Indian J Otolaryngol Head Neck Surg. 2024 Apr;76(2):1796-1804. doi: 10.1007/s12070-023-04416-7. Epub 2023 Dec 27.
2
Valero's host index is useful in predicting radiation-induced trismus and osteoradionecrosis of the jaw risks in locally advanced nasopharyngeal carcinoma patients.瓦莱罗宿主指数可用于预测局部晚期鼻咽癌患者放射性张口困难和颌骨放射性骨坏死的风险。
BMC Cancer. 2023 Jul 12;23(1):651. doi: 10.1186/s12885-023-11155-z.
3
Dental loss after radiotherapy for head and neck cancer.头颈部癌症放疗后牙齿缺失。
Br Dent J. 2021 Oct;231(8):473-478. doi: 10.1038/s41415-021-3536-4. Epub 2021 Oct 22.
4
Xerostomia and Clinical Outcomes in Definitive Intensity Modulated Radiotherapy (IMRT) Three-dimensional Conformal Radiotherapy (3D-CRT) for Head and Neck Squamous Cell Carcinoma: A Meta-analysis.口干症与头颈部鳞癌调强放疗（IMRT）、三维适形放疗（3D-CRT）临床结局的关系：Meta 分析
In Vivo. 2020 Mar-Apr;34(2):623-629. doi: 10.21873/invivo.11816.
5
Risk factors and dose-effect relationship for mandibular osteoradionecrosis in oral and oropharyngeal cancer patients.口腔和口咽癌患者下颌骨放射性骨坏死的危险因素及剂量-效应关系。
Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1084-91. doi: 10.1016/j.ijrobp.2008.12.052. Epub 2009 Mar 26.

关于约瑟夫等人（2023年）（https://doi.org/10.1007/s12070-023-04416-7）。

In Regard to Joseph et al. (2023) (https://doi.org/10.1007/s12070-023-04416-7).

作者信息

Topkan Erkan, Somay Efsun, Selek Ugur, Pehlivan Berrin

机构信息

Department of Radiation Oncology, Faculty of Medicine, Baskent University, Adana, Turkey.

Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Baskent University, 82. Street No: 26, Bahcelievler, Ankara Turkey.

出版信息

Indian J Otolaryngol Head Neck Surg. 2024 Aug;76(4):3735-3736. doi: 10.1007/s12070-024-04580-4. Epub 2024 Mar 11.

DOI:10.1007/s12070-024-04580-4
PMID:39130252
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11306466/
Abstract

We read the study conducted by Joseph and colleagues with great interest, which investigated the loco-regional control, disease-specific survival (DSS), overall survival (OS), and treatment-related complications in 163 oral cancer (OC) patients treated with radiotherapy (RT) or chemo-RT (CRT) for close resection margins (CRMs).The study results offer valuable insights into the role of RT/CRT in OC patients with CRMs, but two concerns must be addressed to interpret the outcomes rigorously.

摘要

我们饶有兴趣地阅读了约瑟夫及其同事进行的研究，该研究调查了163例因切缘接近（CRM）而接受放疗（RT）或放化疗（CRT）的口腔癌（OC）患者的局部区域控制、疾病特异性生存（DSS）、总生存（OS）以及治疗相关并发症。该研究结果为RT/CRT在CRM的OC患者中的作用提供了有价值的见解，但要严谨地解释这些结果，必须解决两个问题。